Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy
Monoclonal antibodies targeting immune checkpoints are gaining ground in the treatment of melanoma and other cancers, and considerable effort is made to identify biomarkers predicting the efficacy of these therapies. Our retrospective study was performed on surgical tissue samples (52 lymph nodes an...
Elmentve itt :
Szerzők: |
Balatoni Tímea Mohos Anita Papp Eszter Sebestyén Tímea Liszkay Gabriella Oláh Judit Magdolna Varga Anita Lengyel Zsuzsanna Emri Gabriella Gaudi István Ladányi Andrea |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2018
|
Sorozat: | CANCER IMMUNOLOGY IMMUNOTHERAPY
67 No. 1 |
doi: | 10.1007/s00262-017-2072-1 |
mtmt: | 3280070 |
Online Access: | http://publicatio.bibl.u-szeged.hu/13923 |
Hasonló tételek
-
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
Szerző: Sarnaik Amod A., et al.
Megjelent: (2021) -
Survival Benefit of Stereotactic Radiotherapy in the Complex Management of Metastatic Melanoma
Szerző: Kelemen Gyöngyi, et al.
Megjelent: (2024) -
Bacterial sepsis increases survival in metastatic melanoma Chlamydophila pneumoniae induces macrophage polarization and tumor regression /
Szerző: Buzás Krisztina, et al.
Megjelent: (2016) -
Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma
Szerző: Ladányi Andrea, et al.
Megjelent: (2020) -
Metastatic melanoma in childhood
Szerző: Szekeres E., et al.
Megjelent: (1986)